Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1-Reference-Cited by-同舟云学术

Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1

Published:2021-02 Issue:2 Volume:32 Page:208-217
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

André F.,Ciruelos E.M.,Juric D.,Loibl S.,Campone M.,Mayer I.A.,Rubovszky G.,Yamashita T.,Kaufman B.,Lu Y.-S.,Inoue K.,Pápai Z.,Takahashi M.,Ghaznawi F.,Mills D.,Kaper M.,Miller M.,Conte P.F.,Iwata H.,Rugo H.S.

Funder

Novartis Pharmaceuticals Corporation

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference24 articles.

1. Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial;Di Leo;Lancet Oncol,2018

2. Mollon L, Aguilar A, Anderson E, et al. A systematic literature review of the prevalence of PIK3CA mutations and mutation hotspots in HR+/HER2– metastatic breast cancer. Paper presented at: American Association for Cancer Research Annual Meeting 2018; 14-17 April 2018; Chicago, IL. Abstract 1207.

3. Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR+, HER2- advanced breast cancer: results from BOLERO-2;Moynahan;Br J Cancer,2017

4. Comprehensive molecular portraits of human breast tumours;Nature,2012

5. Tolaney S, Toi M, Neven P, et al. Clinical significance of PIK3CA and ESR1 mutations in ctDNA and FFPE samples from the MONARCH 2 study of abemaciclib plus fulvestrant. Paper presented at: American Association for Cancer Research Annual Meeting 2019; 29 March - 3 April 2019; Atlanta, GA. Abstract 4458.

Cited by 339 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted gene panel sequencing of liquid and tissue biopsies reveals actionable genomic alterations in Ghanaian metastatic breast cancer cases;Translational Oncology;2024-11

2. The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis;European Journal of Pharmacology;2024-11

3. Identification of activating somatic mutations in the <i>PIK3CA</i> gene in breast tumors and determination of their minimal set for clinical diagnostic testing;Almanac of Clinical Medicine;2024-09-10

4. Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment;Drug Resistance Updates;2024-09

5. Von disseminierten Tumorzellen zur ctDNA – Liquid Biopsies im Mammakarzinom und die Erkenntnisse der letzten 20 Jahre;Senologie - Zeitschrift für Mammadiagnostik und -therapie;2024-09